Clinical Trial Update: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update showing completion of a study evaluating the efficacy, safety, and tolerability of BBT-877 in patients with idiopathic pulmonary f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• BBT-877

Snippet

Sponsor: Bridge Biotherapeutics, Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED